Medicinal cannabis products that meet the minimum quality standard

Generally, medicinal cannabis products are only available, on prescription, if they have:

  • been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
  • obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines)

Any doctor can prescribe a product listed here. A specialist recommendation and Ministerial approval are not required. For more information on a particular product, please contact the listed product supplier or manufacturer.

Products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019

At this time, no applications for product assessments have been received by the Medicinal Cannabis Agency.

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Being listed on this page does not guarantee that these products are currently available in New Zealand.

Products with consent for distribution (approved and provisionally approved) under the Medicines Act 1981

Approved and provisionally approved medicines have been assessed by Medsafe and have demonstrated that they meet New Zealand and internationally recognised standards for quality, safety and efficacy. Approved and provisionally approved medicines are not required to be assessed against the minimum quality standard.

Sativex Oral spray
Active ingredient(s) Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg
Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg
Dose form Oromucosal spray
Sponsor Emerge Health New Zealand Limited
58 Richard Pearse Drive
Airport Oaks, Mangere 2022
Prescribing information Sativex data sheet
Information for consumers Sativex consumer medicine information
Back to top